TSS
NVAX icon

Two Sigma Securities’s Novavax NVAX Stock Holding History

Two Sigma Securities’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-48,700
Closed -$2.5M – 2942
2022
Q2 		$2.5M Sell
48,700
-28,700
-37% -$1.49M 0.09% 254
2022
Q1 		$5.7M Buy
77,400
+75,600
+4,200% +$6.74M 0.2% 105
2021
Q4 		$258K Sell
1,800
-5,600
-76% -$962K 0.01% 908
2021
Q3 		$1.53M Buy
7,400
+5,200
+236% +$1.15M 0.05% 359
2021
Q2 		$467K Buy
+2,200
New +$403K 0.01% 695

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Securities's NVAX Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Novavax (NVAX) in Q1 2026: 13,639 shares worth $111K. The stake represents 0.01% of the portfolio and ranks #1156 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in NVAX as recently as Q2 2023.

Two Sigma Securities first reported a position in NVAX in Q3 2016 and has held it in 11 quarters since. The position peaked at $1.36M in Q1 2022. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Two Sigma Securities held 13,639 shares of Novavax worth $111K as of Q1 2026.
  • Novavax was a new Two Sigma Securities position in Q1 2026.
  • Novavax made up 0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1156 holding.
  • Two Sigma Securities first reported a position in Novavax in Q3 2016 and has held it in 11 quarters since.
  • Two Sigma Securities's Novavax position peaked at $1.36M in Q1 2022.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.